ctrl K

Milestone Pharmaceuticals... (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.32

0.00 (0.00%)

At close: May 01, 2025, 3:59 PM

1.32

-0.38%

Pre-market: May 02, 2025, 09:17 AM EDT

Milestone Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	1M	5M	15M	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	480K	n/a	376K	236K	10K	8K
Gross Profit	n/a	1M	4.52M	15M	-376K	-236K	-10K	-8K
Operating Income	-42.1M	-61.1M	-59.64M	-43.07M	-50.71M	-57.88M	-23.82M	-8.27M
Interest Income	4.16M	3.97M	1.25M	220K	726K	2.6M	711K	186K
Pretax Income	-41.78M	-59.69M	-58.39M	-42.85M	-49.98M	-55.28M	-23.11M	-8.08M
Net Income	-41.52M	-59.69M	-57.13M	-42.63M	-49.97M	-55.23M	-23.18M	-8.09M
Selling & General & Admin	27.1M	31.05M	24.81M	19.4M	16.22M	15.9M	6.97M	2.63M
Research & Development	14.62M	31.05M	39.83M	38.67M	34.49M	41.98M	16.85M	5.64M
Other Expenses	n/a	n/a	n/a	7M	n/a	n/a	n/a	n/a
Operating Expenses	31.1M	62.1M	64.64M	58.07M	50.71M	57.88M	23.82M	8.27M
Interest Expense	-3.58M	2.55M	n/a	n/a	726K	2.6M	n/a	n/a
Selling & Marketing Expenses	10.36M	15.11M	9.1M	7M	5.94M	8.89M	3.92M	1.13M
Cost & Expenses	n/a	62.1M	64.64M	58.07M	50.71M	57.88M	23.82M	8.27M
Income Tax Expense	-41.78M	n/a	-1.25M	-220K	-17K	-56K	74K	4K
Shares Outstanding (Basic)	62.21M	42.96M	42.45M	41.83M	29.34M	15.78M	23.65M	23.65M
Shares Outstanding (Diluted)	62.21M	42.96M	42.45M	41.83M	29.34M	15.78M	23.65M	23.65M
EPS (Basic)	-0.67	-1.39	-1.35	-1.02	-1.7	-3.5	-0.98	-0.34
EPS (Diluted)	-0.67	-1.39	-1.35	-1.02	-1.7	-3.5	-0.98	-0.34
EBITDA	-37.55M	-56.84M	-58.36M	-42.98M	-50.71M	-57.88M	-23.36M	-8.26M
EBIT	-45.36M	-57.13M	-58.84M	-43.07M	-50.36M	-55.68M	-23.37M	-8.27M
Depreciation & Amortization	n/a	92K	480K	362K	376K	236K	10K	8K